EORTC 2024 – Evaluating the Use of Merlin-YAP Dual-label Immunohistochemistry for Predicting Response to TEAD Inhibitor VT3989

Dr. Aisha Mergaert will be attending the ASH Annual Meeting to support her co-authored poster with Solu Therapeutics on December 8 from 6-8 PM at the San Diego Convention Center, […]

Join Discovery at Advanced Therapies Week 2025.    

Join Discovery at Precision Medicine Tri-Con 2025.